Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,800,049
+$4,358,078 QoQ
Shares Held
138,810
+787.2% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 124 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. PHVS ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in PHVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,800,049 | 138,810 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $441,971 | 15,645 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $542,706 | 19,557 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $465,466 | 18,656 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $282,003 | 16,023 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $458,533 | 29,206 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $590,588 | 30,808 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $277 | 15 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $115,074 | 6,121 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $180,442 | 7,808 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $8 | 1 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11 | 1 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $68,585 | 8,942 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $91,338 | 4,133 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $104,674 | 5,772 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,195 | 500 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $8,865 | 500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,246 | 550 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $13,990 | 500 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||